Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Snap Inc. disclosed quarterly financial results for Q2 2026 (three and six months ended June 30, 2026) via press release furnished as Exhibit 99.1. The disclosure includes revenue of $1,599 million (19% YoY growth), net loss of $164 million, Adjusted EBITDA of $250 million, and Free Cash Flow of $121 million, along with detailed financial tables and management commentary from CEO Evan Spiegel. This is a standard earnings release under Item 2.02 that would materially affect investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-03
Item 8.01
News Corporation discloses ongoing execution of its $1 billion share repurchase program authorized July 15, 2025, with daily buy-back notifications to the ASX showing approximately $260.1 million in Class A and Class B stock repurchased as of July 31, 2026. Share repurchases constitute a return of capital to shareholders and are classified as dividend_distribution under the taxonomy, as they represent a capital allocation decision to enhance shareholder value through reduction of outstanding shares.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-03
Item 8.01
News Corp disclosed daily buy-back notifications under its US$1 billion repurchase program authorized July 15, 2025, with approximately US$402.1 million already deployed as of August 3, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The filing shows active execution of the program with specific purchase volumes and prices paid, making this a material capital allocation event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
CNH Industrial N.V. issued a press release on August 3, 2026, announcing its second quarter 2026 financial results, including consolidated revenues of $4.8 billion, net income of $141 million, and diluted EPS of $0.11, along with detailed segment performance and updated full-year 2026 guidance narrowed to the higher end of previous ranges.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
AH Realty Trust issued a press release on August 3, 2026 announcing its second quarter 2026 financial results, including a GAAP net loss of $0.25 per diluted share and FFO As Adjusted of $0.14 per diluted share, while raising full-year 2026 FFO guidance to $0.53–$0.57 per diluted share.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-03
Item 8.01
Liberty Global completed its acquisition of Vodafone Group Plc's 50% shareholding in VodafoneZiggo on July 31, 2026, consolidating ownership and creating Ziggo Group as a new holding company. Vodafone received €1.0 billion in cash and a 10% equity interest in Ziggo Group. Liberty Global intends to pursue a spin-off transaction distributing its 90% equity interest in Ziggo Group to shareholders and listing Ziggo Group on Euronext Amsterdam in 2027.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-03
EX-99.1
Dr. Reddy's announced U.S. FDA approval of its rituximab biosimilar, a significant regulatory milestone for the company's biosimilars portfolio. This is a material operational/strategic event—the approval of a complex biologic medicine in a major market (the U.S.) and the establishment of an exclusive commercialization partnership with Fresenius Kabi. While not a discrete M&A transaction, earnings release, or other named event type, this regulatory approval and market entry represent a material advancement in the company's biosimilars business strategy and competitive position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release for Twist Bioscience's fiscal third quarter 2026 (ended June 30, 2026), disclosing quarterly financial results including revenue of $118.4 million (23% YoY growth), gross margin of 52.8%, and net loss of $35.1 million. The company also raised full-year FY2026 revenue guidance to $456-$457M. The press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
V2X disclosed second quarter 2026 financial results via a press release attached as Exhibit 99.1, including revenue of $1.26 billion (up 17% YoY), net income of $25.5 million, adjusted diluted EPS of $1.64 (up 23% YoY), and increased full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 Results of Operations and Financial Condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Inspire Medical Systems disclosed Q2 2026 financial results (quarter ended June 30, 2026) with revenue of $200.6 million, diluted EPS of $0.01, and adjusted diluted EPS of $0.14, along with raised full-year 2026 guidance and a strategic growth plan (Project Horizon). The earnings announcement was furnished as a press release exhibit accompanying both Item 2.02 and Item 7.01 disclosures.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-08-03
Item 1.01
GoDaddy entered into a Thirteenth Amendment to its credit agreement on July 31, 2026, establishing a new $1,200 million revolving credit facility that refinanced and replaced the existing $1,000 million facility, with a maturity date of July 31, 2031. The $200 million increase in revolving capacity and the five-year extension represent a material creation of a new direct financial obligation and enhancement of the company's liquidity and financial flexibility.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
The filing discloses quarterly financial results for Q2 2026 ended June 30, 2026, including net income of $3.2 million ($0.07 per share) and Core FFO of $37.4 million ($0.78 per share), along with six-month results and updated full-year 2026 guidance. The press release (Exhibit 99.1) is the primary disclosure vehicle, and Item 2.02 explicitly states the company "issued a press release announcing our results of operations for the second quarter ended June 30, 2026."
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
The filing discloses Atkore's financial results for fiscal 2026 third quarter ended June 26, 2026, including net sales of $794.8 million (up 8.1% YoY), net income of $0.7 million, and adjusted EBITDA of $104.7 million. The press release is furnished as Exhibit 99.1 and incorporated by reference in Item 2.02, which is the standard Item for earnings releases. While the filing also mentions an acquisition agreement with Prysmian and a litigation settlement, the primary disclosure under Item 2.02 is the quarterly financial results announcement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-03
Item 8.01
The filing discloses completion of the acquisition of The Advocacy Partners on August 1, 2026, with initial consideration of $20.4 million (comprising $2.04 million in equity and $18.36 million in cash) plus potential earnout payments up to $54.6 million. This is a material acquisition that expands PPHC's state government relations capability and is explicitly described as "earnings and margin accretive," directly affecting the registrant's financial position and strategic footprint.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-08-03
Item 8.01
Strive announced the purchase of 20 bitcoin at approximately $63,191 per bitcoin during July 27-31, 2026, along with detailed updates to its asset holdings and share structure. This disclosure reflects the company's ongoing bitcoin treasury strategy and capital allocation decisions. While the bitcoin purchase itself is a material operational/investment activity for a company with a stated bitcoin treasury strategy, the filing is primarily an update of holdings and financial position rather than a discrete material event like M&A, debt issuance, or impairment. The forward-looking statements reference "Bitcoin treasury strategies" as part of the merger transaction with Semler Scientific, indicating this is part of the company's core operational strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-08-03
Item 1.01
Bowhead Specialty Holdings Inc. entered into a definitive merger agreement on August 2, 2026, whereby American Family Mutual Insurance Company will acquire Bowhead through a merger with Merger Sub, with Bowhead surviving as a wholly-owned subsidiary. The merger consideration is $34.00 per share in cash, subject to stockholder approval and regulatory clearance (HSR Act, Wisconsin and Texas insurance regulators), with customary closing conditions and a $35 million termination fee.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Bowhead disclosed quarterly financial results for the three and six months ended June 30, 2026, with gross written premiums of $297.9 million (28.2% increase), net income of $16.1 million ($0.48 per diluted share), and a combined ratio of 95.9%, announced via press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-03
Item 5.02
The filing discloses the appointment of Amiee Bayer-Thomas to CAVA's Board of Directors effective July 29, 2026, along with her appointment to the Audit Committee and Nominating, Governance and Sustainability Committee. This is a clear director appointment under Item 5.02, representing a material governance change that would affect a reasonable investor's assessment of the company's leadership and board composition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-03
Item 7.01
The filing discloses Oppenheimer Holdings' second quarter 2026 financial results through an investor presentation posted to the company's website. The presentation contains detailed operating results including revenue of $454.9 million, net income of $27.4 million, and earnings per share metrics (both GAAP and non-GAAP adjusted), along with segment breakdowns and comparative analysis versus prior-year periods. This constitutes a quarterly earnings release material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-03
Item 2.02
This is a press release issued on August 3, 2026, disclosing financial and operational results for the second quarter of 2026, specifically highlighting that SenesTech's active online subscription customer base "more than doubled" and e-commerce business "grew 186%" compared to the prior quarter. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The material growth metrics and strategic performance indicators would affect a reasonable investor's assessment of the company's financial condition and operational momentum.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-03
Item 5.02
The Compensation Committee approved forms of performance-based restricted stock unit award agreements on July 28, 2026, to be used for grants to officers and employees under the 2020 Stock Incentive Plan. This is a compensatory arrangement disclosure under Item 5.02(e), establishing the framework for equity awards tied to Hyve Solutions financial performance over a three-year period. The approval of award agreement forms for future grants to named executives and employees is a material executive compensation matter.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "the Company issued a press release announcing its financial results for the quarter ended June 30, 2026," with exhibits attached. The press release reports revenue of $42.7 million (18% YoY growth), B2 Cloud Storage revenue of $26.6 million (34% YoY growth), net loss of $5.1 million, and Adjusted EBITDA of $12.8 million, along with forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Ameresco announced its Q2 2026 financial results on August 3, 2026, disclosing revenues of $515.5 million, net income of $9.7 million, GAAP EPS of $0.18, and adjusted EBITDA of $62.8 million. The company also increased its 2026 Non-GAAP EPS guidance to $1.15–$1.35 based on improved visibility into investment tax credits. The press release (Exhibit 99.1) is the standard earnings announcement format with detailed financial highlights, segment performance, backlog metrics, and full-year guidance, clearly constituting a material earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
People Inc disclosed Q2 2026 financial results with quarterly revenue of $436.7 million, operating loss of $14.3 million, net earnings of $506.9 million (driven by unrealized gains on MGM investment), and Adjusted EBITDA of $55.9 million.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-03
Item 5.02
People Inc appointed Neil Vogel as Chief Executive Officer and Timothy Quinn as Chief Financial Officer, both effective August 5, 2026, representing a significant leadership transition at the registrant.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Medifast issued a press release on August 3, 2026 announcing its second quarter 2026 financial results, including revenue of $76.4 million, a net loss of $3.1 million ($0.28 loss per diluted share), and key operational metrics. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
UFP Technologies issued a press release on August 3, 2026, announcing its financial results for the second quarter ended June 30, 2026. The disclosure reports net income of $20.9 million (21.4% higher than Q2 2025), net sales of $174.0 million (15.1% higher than Q2 2025), and record quarterly results. This is a standard earnings release disclosing quarterly financial results, furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
GeneDx issued a press release on August 3, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $114.4 million, exome and genome volume growth of 32% year-over-year, adjusted gross margin of 70%, and adjusted net income of $0.4 million. The filing explicitly states the company "issued a press release" and "will hold a conference call announcing the Company's financial results," with copies of the Press Release and Earnings Presentation furnished as exhibits. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Ultra Clean Holdings issued a press release on August 3, 2026 announcing its financial results for the second fiscal quarter ended June 26, 2026, disclosing GAAP and non-GAAP results including revenue of $644.9 million, net income of $8.7 million ($0.19 per diluted share), and forward guidance for Q3 2026. This is a standard quarterly earnings release disclosed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-03
Mr. Charles Mathias, a member of Pelagos Insurance Capital Limited's Board of Directors and member of the Risk Committee and Investment Committee, announced his resignation effective August 2, 2026. This is a clear departure of a director from the board and committee roles, which is material to investors as board composition and committee membership affect governance and oversight.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-03
Item 5.02
The filing discloses that Therese Tucker, Founder and Board member, retired from full-time employment effective June 2, 2026. While the filing also describes a subsequent consulting agreement entered into on July 31, 2026, the principal material event is her departure from full-time employment. The consulting arrangement is ancillary to the departure and does not constitute a new appointment to an executive role.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-08-03
EX-99.1
The exhibit is a press release announcing a quarterly dividend declaration by Pelagos Insurance Capital Limited. The Board of Directors has approved and declared a dividend of $0.15 per common share, payable on September 25, 2026, to shareholders of record on September 14, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 3, 2026. The Item 2.02 disclosure explicitly states that Ibotta issued a press release announcing financial results, with the full earnings release furnished as Exhibit 99.1. The release contains detailed financial statements, performance metrics, revenue guidance, and management commentary on quarterly results, which are hallmarks of an earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a straightforward earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02. The press release discloses record quarterly revenue of $52.7 million, record bookings of $113.0 million, record backlog of $335.5 million, and raised full-year 2026 revenue guidance to $275–$305 million (66–84% YoY growth). The exhibit (EX-99.1) is the formal earnings announcement issued on August 3, 2026, which is the standard format for earnings disclosures on Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
3D Systems issued a press release on August 3, 2026 announcing Q2 2026 financial results for the period ended June 30, 2026. The disclosure includes detailed revenue ($94.6M), net loss ($12.9M), Adjusted EBITDA, segment performance, and forward guidance for Q3 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
JBT Marel Corporation issued a press release on August 3, 2026, announcing financial results for Q2 2026 ended June 30, 2026. The disclosure includes consolidated revenue of $981 million (up 5%), net income of $28 million, diluted EPS of $0.54, adjusted EBITDA of $168 million, and full-year 2026 guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Governance Other
confidence 65%
filed 2026-08-03
Item 5.03
The Company disclosed a material modification to security holder rights through amendments to its Certificate of Incorporation and Bylaws, incorporating governance changes related to Class B Common Stock reclassification, officer exculpation, and procedural updates for stockholder meetings and director nominations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-08-03
Item 1.01
Amneal Pharmaceuticals entered into Amendment No. 3 to its Term Loan Credit Agreement on August 3, 2026, involving a repricing and restructuring of approximately $2.084 billion in term loans ($2.039 billion converted plus $45.2 million new), with an estimated annual interest expense reduction of approximately $12 million.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-08-03
Item 5.02
D. Keith Oden is retiring from his position as Executive Vice Chairman of the Board of Trust Managers effective August 31, 2026. Although he will remain on the Board, the departure from an executive officer role (Executive Vice Chairman) is the principal disclosed action and constitutes a material executive departure. The filing is made under Item 5.02, which covers departures of officers and directors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Commercial Vehicle Group announced Q2 2026 financial results with revenues of $195.2 million, EPS of $(0.25), and Adjusted EBITDA of $5.4 million, along with raised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-03
Item 7.01
The filing discloses a previously announced merger agreement between BioLife Solutions and Repligen Corporation, with a two-step merger structure (First Merger and Second Merger) resulting in BioLife becoming a wholly owned subsidiary of Repligen. The Item 7.01 disclosure provides supplemental information regarding the transaction through an employee video and email from management, confirming the transaction remains pending regulatory and shareholder approvals with expected close in Q4 2026. This is a material acquisition/change of control event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Black Stone Minerals issued a press release on August 3, 2026, announcing its second quarter 2026 financial and operating results, including net income of $106.4 million, Adjusted EBITDA of $91.3 million, and distributable cash flow of $80.4 million. The filing discloses that the press release contained an error in reporting mineral and royalty interest acquisitions ($48.7 million reported instead of $37.2 million for Q2), but the core event is the earnings release itself, which is material to investors assessing the registrant's financial performance and cash generation capacity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Ares Commercial Real Estate Corp issued its Q2 2026 earnings release on August 4, 2026, reporting GAAP net income of $4.4 million ($0.08 per diluted share) and Distributable Earnings of $6.9 million ($0.12 per diluted share), along with a declared dividend of $0.15 per share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release disclosing Ichor Holdings' second quarter 2026 financial results. The filing explicitly states "On August 3, 2026, Ichor Holdings, Ltd. (the "Company") issued a press release announcing second quarter 2026 financial results" and includes detailed GAAP and non-GAAP financial metrics (revenue of $294.8M, net income of $1.0M, diluted EPS of $0.03), along with forward guidance for Q3 2026. The press release is furnished as Exhibit 99.1 and is the primary content of Item 2.02.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-03
National Grid announces a significant restructuring of its operating model effective 1 September 2026, reducing the Group Executive Committee from 13 to 8 members and reorganizing leadership under geographic presidents (UK and US) and new functional heads. The announcement includes multiple executive appointments (Cordi O'Hara as President UK, Sally Librera as Interim President US, Carl Trowell as President of Global Capital, and Alice Delahunty as Chief Technology and Innovation Officer), representing material governance and organizational changes that would affect investor assessment of management structure and accountability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-08-03
Item 2.02
The filing discloses Q2 2026 financial results for the period ended June 30, 2026, including revenue of $25.1 million (with $24.0 million in product revenue from PALSONIFY), operating expenses, and net loss of $120.9 million. However, the press release is dominated by the announcement of Vertex's acquisition of Crinetics for $85.00 per share ($10.0 billion total equity value), which is the lead headline and primary business development. While Item 2.02 technically covers earnings results, the material event here is the M&A transaction, not the earnings themselves.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a straightforward quarterly earnings release for Q2 2026 filed under Item 2.02. The press release (Exhibit 99.1) discloses financial results including net loss of $28.7 million, R&D expenses of $22.3 million, cash position of $257.6 million, and cash runway guidance into H1 2028. The filing explicitly states the press release was issued on August 3, 2026 announcing financial results for the quarter ended June 30, 2026, with condensed consolidated financial statements attached.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-08-03
Item 1.01
Atkore Inc. entered into a definitive Agreement and Plan of Merger with Prysmian S.p.A. on August 2, 2026, providing for the acquisition of all outstanding shares of Atkore common stock at $95.00 per share in an all-cash transaction valued at approximately $3.8 billion, representing a 30% premium to the closing price on July 31, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
JELD-WEN issued a press release on August 3, 2026, announcing second quarter 2026 financial results with net revenues of $817.8 million, net loss from continuing operations of ($31.5) million, and Adjusted EBITDA of $42.3 million, along with updated full-year 2026 guidance raising the Adjusted EBITDA range to $120–$150 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Innovative Industrial Properties disclosed Q2 2026 financial results ended June 30, 2026, reporting total revenues of $63.3 million, net income of $40.7 million ($1.36 per diluted share), and AFFO of $53.0 million ($1.83 per share), along with a declared dividend of $1.90 per share. The disclosure included consolidated financial statements and supplemental information via press release and investor presentation.
View raw filing on EDGAR →